Adverse effects of androgen deprivation therapy and strategies to mitigate them.
about
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contraIntegrating diet and exercise into care of prostate cancer patients on androgen deprivation therapyMolecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerAndrogen deprivation therapy and cardiovascular disease: what is the linking mechanism?Role of Dose Intensification for Salvage Radiation Therapy after Radical ProstatectomyHormone naïve prostate cancer: predicting and maximizing response intervalsLifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an updateAndrogen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive reviewNutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocolPatients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorderBrachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product.A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal OestradiolAssociation of Androgen Deprivation Therapy With Depression in Localized Prostate CancerMortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer: A systematic review with direct and network meta-analyses of randomized controlled trials and observational studiesCardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer.The role of mindfulness in distress and quality of life for men with advanced prostate cancerLithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells.Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study.The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer.Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway.The role of dietary fat throughout the prostate cancer trajectory.Management of metastatic hormone-sensitive prostate cancer.Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.The use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update.Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysisHigh-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : A systematic review.The implications of ageing and life expectancy in prostate cancer treatment.Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients.Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer.Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer.Metformin and Prostate Cancer: a New Role for an Old Drug.Qigong/tai chi for sleep and fatigue in prostate cancer patients undergoing radiotherapy: a randomized controlled trial.Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer.Rationale for the development of alternative forms of androgen deprivation therapy.Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer.Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.Development and Initial Validation of the Novel Scale for Assessing Quality of Life of Prostate Cancer Patients Receiving Androgen Deprivation Therapy.Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer.
P2860
Q24289204-338CCA40-3CD8-4366-9D43-2B06634993E9Q26738281-30AC5282-FC9E-4A31-AB10-413C3756A5A3Q26739708-D3FE1C8C-0DF0-4CFA-9AAD-B04BACA21A64Q26749088-75167DDF-6AA0-4F4E-9533-E3AD79945CFAQ26765872-8C16F9CF-522A-4AF4-9F08-588FD21B1532Q27015904-5E5B03D9-26DD-4C43-852A-7FF047749DB4Q33900049-0689495F-ED38-46E1-8ECB-587DAC6288A2Q35774987-8AC87B84-0709-4B35-BB2D-BAE6ACBF44B6Q35969717-D325FDB4-4FB7-4530-81AB-5F4E931F4FB1Q36238990-17BFD0BB-6F9D-4599-B147-7F7E04EEF1AFQ36295478-8371972E-E3A4-4A9F-AFC2-7FC8E6FAE83CQ36690539-9341A755-5AFD-45BF-A7ED-C30ED38AE15FQ36814686-2F0D5293-C80E-4852-A671-EB55E3E032B3Q36861650-AF7A855B-42E9-43AA-BE13-F3C778D5CCDEQ37137956-4D9C760B-41E8-4A1F-8389-064E429B8CBEQ37205661-CD84C8AF-FD8E-49E7-9761-EA330E866C0BQ37269889-9ECFE390-D50A-4E36-A676-1DF8C9AFF73DQ37405151-4EB6CFA6-A011-41F5-8AD8-EAB285715280Q37428836-52E1CF1D-3FF0-4A1D-917A-DEC49E89EDE7Q37681344-B80AA564-F0EB-49B5-9BF8-32B1B210F20EQ37708169-5864AD04-18C9-41A8-9CEA-E65BC047361CQ37739979-CF189ACD-72E5-466D-8C0D-D0C5125101CFQ38297476-22C1F443-6E6C-4F1E-879D-22A6B25615B3Q38353835-52FCCF26-1ABA-426F-8062-F9BEF3717D25Q38587219-AFF231C9-E515-4417-A9B8-04707197E32AQ38673916-E2F18E21-B3C2-43EC-8E0F-F8609CE1F330Q38691070-78AFC1FC-9111-4020-8AAE-DB41801A08FAQ38721676-19CFB162-22BE-4C51-9E4B-E6881020C20FQ38784043-37DDDF5E-202B-499F-ADEE-F2DA7230575FQ38786134-68836F56-76FF-4EDA-9CFD-AE6F23ED2573Q38796656-B5FE2C66-5FBF-450C-A24C-D52CC2BED2C6Q38798811-C81F5430-578D-471B-AEE3-A3EF7E3FAF4BQ38819039-A5FA3D05-7317-45F0-8E8D-4B47BC64E996Q38829002-8EC2D64D-A0A7-4526-BA71-78DC19769006Q39003600-EDF28083-DD56-4E8C-8B2B-D40BF9755489Q39342369-804AB565-BCF2-4365-BD07-31570074E60DQ39734559-E8A983FA-66C7-413C-9A18-59E1F3491428Q40057603-ED5FD57D-98D6-4946-BCB5-38E717D4B767Q40072512-F258B51F-B84F-4F54-B4B7-71D521F139C6Q40112597-044531B2-A1AE-49B1-A7CC-DAE2BA4856A4
P2860
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@ast
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@en
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@nl
type
label
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@ast
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@en
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@nl
prefLabel
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@ast
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@en
Adverse effects of androgen deprivation therapy and strategies to mitigate them.
@nl
P2093
P50
P1433
P1476
Adverse effects of androgen deprivation therapy and strategies to mitigate them
@en
P2093
Anthony V D'Amico
Bertrand Tombal
Derek J Rosario
Matthew R Smith
Nancy L Keating
Paul L Nguyen
Shehzad Basaria
P304
P356
10.1016/J.EURURO.2014.07.010
P407
P577
2014-08-02T00:00:00Z